323 related articles for article (PubMed ID: 23684750)
21. Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.
von Hahn T; Schiene-Fischer C; Van ND; Pfaender S; Karavul B; Steinmann E; Potthoff A; Strassburg C; Hamdi N; Abdelaziz AI; Sarrazin C; Müller T; Berg T; Trépo E; Wedemeyer H; Manns MP; Pietschmann T; Ciesek S
Gastroenterology; 2012 Aug; 143(2):439-47.e1. PubMed ID: 22580540
[TBL] [Abstract][Full Text] [Related]
22. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus.
Ito T; Mukaigawa J; Zuo J; Hirabayashi Y; Mitamura K; Yasui K
J Gen Virol; 1996 May; 77 ( Pt 5)():1043-54. PubMed ID: 8609470
[TBL] [Abstract][Full Text] [Related]
23. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
[TBL] [Abstract][Full Text] [Related]
24. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus.
Roelandt P; Obeid S; Paeshuyse J; Vanhove J; Van Lommel A; Nahmias Y; Nevens F; Neyts J; Verfaillie CM
J Hepatol; 2012 Aug; 57(2):246-51. PubMed ID: 22521345
[TBL] [Abstract][Full Text] [Related]
25. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
[TBL] [Abstract][Full Text] [Related]
26. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.
Banaudha K; Orenstein JM; Korolnek T; St Laurent GC; Wakita T; Kumar A
Hepatology; 2010 Jun; 51(6):1922-32. PubMed ID: 20512986
[TBL] [Abstract][Full Text] [Related]
27. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
Abe K; Ikeda M; Dansako H; Naka K; Shimotohno K; Kato N
Virus Res; 2005 Jan; 107(1):73-81. PubMed ID: 15567036
[TBL] [Abstract][Full Text] [Related]
28. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.
Schaefer EA; Meixiong J; Mark C; Deik A; Motola DL; Fusco D; Yang A; Brisac C; Salloum S; Lin W; Clish CB; Peng LF; Chung RT
World J Gastroenterol; 2016 Dec; 22(45):9954-9965. PubMed ID: 28018102
[TBL] [Abstract][Full Text] [Related]
33. Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand.
Matsunobu T; Okuno T; Yokoyama C; Yokomizo T
J Lipid Res; 2013 Nov; 54(11):2979-87. PubMed ID: 24009185
[TBL] [Abstract][Full Text] [Related]
34. Generation of thromboxane A2 from highly purified human sinus mast cells after immunological stimulation.
Mita H; Ishii T; Akiyama K
Prostaglandins Leukot Essent Fatty Acids; 1999 Mar; 60(3):175-80. PubMed ID: 10359019
[TBL] [Abstract][Full Text] [Related]
35. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
Denolly S; Granier C; Fontaine N; Pozzetto B; Bourlet T; Guérin M; Cosset FL
J Hepatol; 2019 Apr; 70(4):626-638. PubMed ID: 30553840
[TBL] [Abstract][Full Text] [Related]
36. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
[TBL] [Abstract][Full Text] [Related]
37. TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
Boyer A; Park SB; de Boer YS; Li Q; Liang TJ
Gastroenterology; 2018 Dec; 155(6):1923-1935.e8. PubMed ID: 30144428
[TBL] [Abstract][Full Text] [Related]
38. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
[TBL] [Abstract][Full Text] [Related]
39. Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel.
Sathler PC; Santana M; Lourenço AL; Rodrigues CR; Abreu P; Cabral LM; Castro HC
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):527-31. PubMed ID: 23914925
[TBL] [Abstract][Full Text] [Related]
40. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
